RxDoctor Payments DataLook up a doctor →

Joseph Legaspi, MD

Internal Medicine · Schererville, INNPI 1104826676

Payments from drug & device makers

$18,955in general payments, 2019–2025

Across 855 payments — averaging $22.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$4K
  • AbbVie$3K
  • Nestle Healthcare Nutrition Inc.$933
  • AstraZeneca$919
  • Otsuka America Pharmaceutical, Inc.$717
  • Novo Nordisk$685
  • plus $9K from 52 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen166$4,046
AbbVie(2 entities)209$2,940
Nestle Healthcare Nutrition Inc.56$933
AstraZeneca(2 entities)38$919
Otsuka America Pharmaceutical, Inc.29$717
Novo Nordisk33$685
Johnson & Johnson(2 entities)8$612
Axsome Therapeutics, Inc.14$566
Lilly USA, LLC28$523
Novartis22$518
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC25$493
Abbott8$470
Boehringer Ingelheim20$416
Bayer13$399
Vanda Pharmaceuticals Inc.18$385
Xeris Pharmaceuticals, Inc.15$370
Vifor Pharma, Inc.7$305
Pfizer14$248
Antares Pharma, Inc.12$211
Radius Health, Inc.8$196
Phathom Pharmaceuticals, Inc.6$189
Amneal Pharmaceuticals LLC14$184
Cequr Corporation2$179
Sirtex Medical Inc1$146
Sanofi-aventis U.S. LLC6$140
Aimmune Therapeutics, Inc.6$139
Genentech USA, Inc.1$136
Idorsia Pharmaceuticals US Inc8$136
GSK7$131
Amarin Pharma, Inc.3$126
Regeneron Healthcare Solutions, Inc.1$126
Dexcom, Inc.4$117
Exact Sciences5$115
Karyopharm Therapeutics Inc.1$102
Viatris Specialty LLC4$101
Optinose US, Inc.1$101
Kowa Pharmaceuticals America, Inc.6$97
AMAG Pharmaceuticals, Inc.1$87
Lundbeck LLC4$77
Almatica Pharma LLC4$72
Mylan Specialty L.p.4$71
Vertex3$57
Merck3$48
Inspire Medical Systems, Inc.1$44
Takeda Pharmaceuticals U.S.A., Inc.2$44
Corcept Therapeutics1$32
Astellas Pharma US Inc1$32
Esperion Therapeutics, Inc.1$23
Sanofi Pasteur Inc.1$19
Biogen1$18
Halozyme Inc1$17
Teva Pharmaceuticals USA, Inc.1$16
Scilex Pharmaceuticals Inc.1$15
E.r. Squibb & Sons, L.L.C.1$15
Evoke Pharma, Inc.1$15
Hikma Pharmaceuticals USA1$15
Ironwood Pharmaceuticals, Inc1$14
Clarus Therapeutics Inc.2$9

How this compares

$18,955 in reported general payments places this provider in the 95th percentile of 1,747 internal medicine providers in Indiana.

See all internal medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$373,719
Medicare patients
908
Services billed
5,058

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Schererville

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →